Crispr-bolag pausar studier efter rapport om allvarliga biverkningar

En allvarlig leverpåverkan hos en patient gör att amerikanska Intellia Therapeutics nu stoppar behandling och rekrytering i fas 3-studier med företagets genterapi.

Del 5 i Advance serien: Projektsupport & Driftsättning

Spirax Sarco säkerställer att alla system och komponenter levereras i full överensstämmelse med kundens operativa krav, från teknisk design och installation til...

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

Polymer Factory Sweden AB

SMC Automation AB

Grattis på 65-årsdagen SMC Corporation!

65 fartfyllda år. Och vi har det bästa framför oss.

Nanexa utvecklar depåberedning av diabetes- och fetmaläkemedlet Saxenda

Uppsalabaserade Nanexa har slutit ett avtal med ett tyskt kontraktsforskningsbolag för att starta en klinisk studie med en månadsdepå av liraglutid. Läkemedlet ...

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

The art of building a biologic drug

The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...

Recipharm divests five Swedish plants

Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...

Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Sweden is heavily criticised for not ordering Covid vaccine

Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.

40,000 DNA extractions daily

It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Här visar Astra Zeneca framtidens läkemedelsfabrik

Automatisering är ledordet i framtidens läkemedelsfabrik. I veckan visade Astra Zeneca hur den kan se ut när man slog upp dörren till företagets "Smart Factory ...

Ny chef på Nanexa

Björn Svanström är företagets nya finanschef.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

En återfödelse i innovationens namn

DMC Automation från Turin har skapat en robotenhet som är utrustad med komponenter från SMC innehållande ett innovativt trådlöst styrsystem. Detta är ett stabil...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...

Scandicure tar nästa steg med franskt kontrakt

Ingår avtal med Servier om forskning inom metabola sjukdomar.